🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 18 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/02/2003 | 7,55 | 7,57 | 7,45 | 7,53 | +0,33% | 1,52% | 323.600 |
| 10/02/2003 | 7,35 | 7,60 | 7,25 | 7,50 | +0,00% | 4,76% | 99.200 |
| 07/02/2003 | 7,48 | 7,63 | 7,43 | 7,50 | +0,07% | 2,61% | 115.800 |
| 06/02/2003 | 7,40 | 7,50 | 7,20 | 7,50 | +1,08% | 3,99% | 189.200 |
| 05/02/2003 | 7,30 | 7,53 | 7,30 | 7,42 | +0,88% | 3,08% | 171.000 |
| 04/02/2003 | 7,45 | 7,49 | 7,23 | 7,35 | -1,87% | 3,49% | 117.600 |
| 03/02/2003 | 7,75 | 7,79 | 7,42 | 7,49 | -2,98% | 4,77% | 275.800 |
| 31/01/2003 | 7,71 | 7,80 | 7,67 | 7,72 | -0,39% | 1,69% | 194.000 |
| 30/01/2003 | 7,70 | 7,85 | 7,70 | 7,75 | -0,32% | 1,95% | 157.400 |
| 29/01/2003 | 7,75 | 7,87 | 7,70 | 7,78 | -0,58% | 2,13% | 377.200 |
| 28/01/2003 | 7,87 | 7,89 | 7,75 | 7,82 | +0,51% | 1,72% | 150.000 |
| 27/01/2003 | 7,83 | 7,85 | 7,66 | 7,78 | -0,58% | 2,49% | 301.000 |
| 24/01/2003 | 8,06 | 8,06 | 7,73 | 7,83 | -3,22% | 4,09% | 286.800 |
| 23/01/2003 | 8,01 | 8,10 | 7,78 | 8,09 | +0,68% | 4,00% | 421.200 |
| 22/01/2003 | 8,09 | 8,09 | 7,91 | 8,03 | -0,56% | 2,22% | 392.000 |
| 21/01/2003 | 8,04 | 8,10 | 8,00 | 8,08 | -1,34% | 1,18% | 179.000 |
| 17/01/2003 | 8,20 | 8,30 | 8,10 | 8,19 | -1,27% | 2,38% | 198.400 |
| 16/01/2003 | 8,20 | 8,50 | 8,09 | 8,29 | +0,97% | 5,00% | 554.800 |
| 15/01/2003 | 8,04 | 8,33 | 8,00 | 8,21 | +2,63% | 4,11% | 509.600 |
| 14/01/2003 | 7,83 | 8,03 | 7,74 | 8,00 | +2,89% | 3,71% | 852.800 |
| 13/01/2003 | 7,92 | 8,03 | 7,73 | 7,78 | -2,14% | 3,85% | 603.000 |
| 10/01/2003 | 8,12 | 8,12 | 7,84 | 7,95 | -1,55% | 3,45% | 710.000 |
| 09/01/2003 | 8,30 | 8,34 | 8,03 | 8,07 | -2,24% | 3,80% | 450.600 |
| 08/01/2003 | 8,46 | 8,53 | 8,25 | 8,26 | -2,88% | 3,25% | 253.600 |
| 07/01/2003 | 8,53 | 8,55 | 8,28 | 8,50 | -0,12% | 3,17% | 318.600 |
| 06/01/2003 | 8,43 | 8,53 | 8,30 | 8,51 | -0,18% | 2,73% | 160.800 |
| 03/01/2003 | 8,58 | 8,59 | 8,41 | 8,53 | -0,29% | 2,10% | 116.200 |
| 02/01/2003 | 8,40 | 8,65 | 8,38 | 8,55 | +2,40% | 3,21% | 240.600 |
| 31/12/2002 | 8,45 | 8,50 | 8,25 | 8,35 | -0,89% | 2,96% | 353.600 |
| 30/12/2002 | 8,50 | 8,56 | 8,14 | 8,43 | -1,35% | 5,00% | 236.600 |